Results 81 to 90 of about 17,273 (236)

UEG Week 2023 Poster Presentations

open access: yes, 2023
United European Gastroenterology Journal, Volume 11, Issue S8, Page 535-1498, October 2023.
wiley   +1 more source

Direct detection and characterization of foot-and-mouth disease virus in East Africa using a field-ready real-time PCR platform [PDF]

open access: yes, 2017
Effective control and monitoring of foot-and-mouth disease (FMD) relies upon rapid and accurate disease confirmation. Currently, clinical samples are usually tested in reference laboratories using standardized assays recommended by The World Organisation
Armson, B.   +16 more
core   +1 more source

Assessment of Single‐Cycle M‐Protein Mutated Vesicular Stomatitis Virus as a Safe and Immunogenic Mucosal Vaccine Platform for SARS‐CoV‐2 Immunogen Delivery

open access: yesAdvanced Science, Volume 11, Issue 47, December 18, 2024.
The VSVMT‐S2P vaccine candidate, featuring a SARS‐CoV‐2 pre‐fusion state spike protein mutant, is safe in healthy and immunocompromised animals. With only single inoculation via various routes of administration, VSVMT‐S2P can stimulate effective and comprehensive immune responses in vivo, especially via the intramuscular route.
En Zhang   +8 more
wiley   +1 more source

Selection of single-chain antibodies that specifically interact with vesicular stomatitis virus (VSV) nucleocapsid and inhibit viral RNA synthesis. [PDF]

open access: yes, 2005
International audienceThe RNA genome of non-segmented negative-strand RNA viruses is completely covered by the nucleoprotein (N) forming a ribonucleoprotein complex, the nucleocapsid.
Cortay, Jean-Claude   +2 more
core   +3 more sources

Using Vesicular Stomatitis Virus as a Platform for Directed Protease Evolution

open access: yesCurrent Protocols, Volume 4, Issue 12, December 2024.
Abstract Antiviral drugs are essential medications to save the lives of infected people. However, they are under constant threat to become ineffective as viruses evolve quickly. Studying the development of resistance is therefore paramount to understand the impact of mutations on pharmacological treatment and to make informed decisions.
Francesco Costacurta   +3 more
wiley   +1 more source

ISEV2023 Abstract Book

open access: yes, 2023
Journal of Extracellular Vesicles, Volume 12, Issue S1, May 2023.
wiley   +1 more source

Merida virus, a putative novel rhabdovirus discovered in Culex and Ochlerotatus spp. mosquitoes in the Yucatan Peninsula of Mexico. [PDF]

open access: yes, 2016
Sequences corresponding to a putative, novel rhabdovirus [designated Merida virus (MERDV)] were initially detected in a pool of Culex quinquefasciatus collected in the Yucatan Peninsula of Mexico.
Blitvich, Bradley J   +7 more
core   +5 more sources

Oncolytic Recombinant Vesicular Stomatitis Virus (VSV) Is Nonpathogenic and Nontransmissible in Pigs, a Natural Host of VSV.

open access: yesHuman Gene Therapy Clinical Development, 2017
Vesicular stomatitis virus (VSV) is a negative-stranded RNA virus that naturally causes disease in livestock including horses, cattle and pigs. The two main identified VSV serotypes are New Jersey (VSNJV) and Indiana (VSIV). VSV is a rapidly replicating,
L. Velázquez-Salinas   +5 more
semanticscholar   +1 more source

Vesicular Stomatitis Virus as a Platform for Protease Activity Measurements

open access: yesCurrent Protocols, Volume 4, Issue 11, November 2024.
Abstract Protease inhibitors are among the most powerful antiviral drugs. They have been used successfully against viruses, such as the human immunodeficiency virus (HIV), hepatitis C virus (HCV) and severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2).
Stefanie Rauch   +3 more
wiley   +1 more source

Abstracts

open access: yes, 2022
JPGN Reports, Volume 3, Issue S1, September 2022.
wiley   +1 more source

Home - About - Disclaimer - Privacy